Hostname: page-component-8448b6f56d-mp689 Total loading time: 0 Render date: 2024-04-18T21:04:55.869Z Has data issue: false hasContentIssue false
  • English
  • Français

Bipolar disorder and adiposity: a study using whole body dual energy X-ray absorptiometry scans

Published online by Cambridge University Press:  24 June 2014

Lana J. Williams ,
Julie A. Pasco ,
Felice N. Jacka ,
Margaret J. Henry ,
Seetal Dodd ,
Geoffrey C. Nicholson ,
Mark A. Kotowicz  and
Michael Berk
Lana J. Williams*
Affiliation:
School of Medicine, Deakin University, Geelong, Australia Department of Psychiatry, University of Melbourne, Parkville, Australia
Julie A. Pasco
Affiliation:
School of Medicine, Deakin University, Geelong, Australia
Felice N. Jacka
Affiliation:
School of Medicine, Deakin University, Geelong, Australia Department of Psychiatry, University of Melbourne, Parkville, Australia
Margaret J. Henry
Affiliation:
School of Medicine, Deakin University, Geelong, Australia
Seetal Dodd
Affiliation:
School of Medicine, Deakin University, Geelong, Australia Department of Psychiatry, University of Melbourne, Parkville, Australia
Geoffrey C. Nicholson
Affiliation:
Rural Clinical School, University of Queensland, Toowoomba, Australia
Mark A. Kotowicz
Affiliation:
NorthWest Academic Centre, Department of Medicine, University of Melbourne, Footscray, Australia
Michael Berk
Affiliation:
School of Medicine, Deakin University, Geelong, Australia Department of Psychiatry, University of Melbourne, Parkville, Australia
*
Dr Lana Williams, School of Medicine, Psychiatric Research Unit: Barwon Health, Deakin University, PO Box 281, Geelong 3220, Australia. Tel: +61 3 5260 3085; Fax: +61 3 5246 5165; E-mail: lanaw@barwonhealth.org.au
Get access Rights & Permissions [Opens in a new window]

Extract

Williams LJ, Pasco JA, Jacka FN, Henry MJ, Dodd S, Nicholson GC, Kotowicz MA, Berk M. Bipolar disorder and adiposity: a study using whole body dual energy X-ray absorptiometry scans.

Objective: Previous research has demonstrated a relationship between adiposity and bipolar disorder, although data are derived predominantly from patient samples and use indirect methods of assessing adiposity. This study investigated the association between bipolar disorder and several indices of adiposity, including body fat mass as measured by dual energy X-ray absorptiometry (DXA), in a community-based sample.

Methods: In this study, 21 women with bipolar disorder and 523 healthy controls were drawn from an age-stratified, random, community-based sample of women (20–93 years) participating in the Geelong Osteoporosis Study. Bipolar disorder was diagnosed utilising a semi-structured clinical interview. Anthropometric measurements (weight, height, waist and hip circumference) were taken and fat mass was determined from whole body DXA scans (Lunar DPX-L).

Results Those with bipolar disorder tended to have greater adiposity. Age-adjusted mean (95% CI) values for bipolar versus controls according to adiposity indices were weight 75.6 (68.9–82.3) versus 72.6 (71.3–74.0) kg, waist circumference 89.8 (84.1–95.6) versus 87.3 (86.1–88.5) cm, waist:hip ratio 0.85 (0.82–0.87) versus 0.84 (0.83–0.84), body mass index 27.6 (25.1–30.1) versus 27.5 (27.0–28.0) kg/m2, fat mass 31.4 (26.5–36.3) versus 28.6 (27.5–29.5) kg and %body fat 40.4 (36.9–43.9) versus 38.0 (37.3–38.7)%; all p > 0.05. Further adjustment for height, smoking, alcohol, psychotropic medication, energy intake or physical activity did not influence these patterns.

Conclusion Although a pattern suggestive of greater adiposity among those with bipolar disorder was observed, no significant differences were detected. We cannot exclude the possibility of a type II error. Further research with a larger sample may produce more conclusive results.

Keywords

adipositybipolar disorderbody compositiondual energy X-ray absorptiometry scanspsychiatric epidemiology
Type
Research Article
Information
Acta Neuropsychiatrica , Volume 23 , Issue 5 , October 2011 , pp. 219 - 223
Copyright
Copyright © Cambridge University Press 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1 Calkin, C, van de Velde, C, Ruzickova, M et al. Can body mass index help predict outcome in patients with bipolar disorder? Bipolar Disord 2009;11:650–656. CrossRefGoogle ScholarPubMed
2 Maina, G, Salvi, V, Vitalucci, A, D'Ambrosio, V, Bogetto, F. Prevalence and correlates of overweight in drug-naive patients with bipolar disorder. J Affect Disord 2008;110:149–155. CrossRefGoogle ScholarPubMed
3 Shah, A, Shen, N, El-Mallakh, RS. Weight gain occurs after onset of bipolar illness in overweight bipolar patients. Ann Clin Psychiatry 2006;18:239–241. CrossRefGoogle ScholarPubMed
4 Fagiolini, A, Kupfer, DJ, Houck, PR, Novick, DM, Frank, E. Obesity as a correlate of outcome in patients with bipolar I disorder. Am J Psychiatry 2003;160:112–117. CrossRefGoogle ScholarPubMed
5 McElroy, SL, Frye, MA, Suppes, T et al. Correlates of overweight and obesity in 644 patients with bipolar disorder. J Clin Psychiatry 2002;63:207–213. CrossRefGoogle ScholarPubMed
6 Fagiolini, A, Frank, E, Houck, PR et al. Prevalence of obesity and weight change during treatment in patients with bipolar I disorder. J Clin Psychiatry 2002;63:528–533. CrossRefGoogle ScholarPubMed
7 Elmslie, JL, Silverstone, JT, Mann, JI, Williams, SM, Romans, SE. Prevalence of overweight and obesity in bipolar patients. J Clin Psychiatry 2000;61:179–184. CrossRefGoogle ScholarPubMed
8 Kolotkin, RL, Corey-Lisle, PK, Crosby, RD et al. Impact of obesity on health-related quality of life in schizophrenia and bipolar disorder. Obesity (Silver Spring) 2008;16: 749–754. CrossRefGoogle ScholarPubMed
9 Kretschmer, E. Physique and character. London: Kegan, Paul, Trench, Trubner, 1936.Google Scholar
10 Keck, PE, McElroy, SL. Bipolar disorder, obesity, and pharmacotherapy-associated weight gain. J Clin Psychiatry 2003;64:1426–1435. CrossRefGoogle ScholarPubMed
11 Hennen, J, Perlis, RH, Sachs, G, Tohen, M, Baldessarini, RJ. Weight gain during treatment of bipolar I patients with olanzapine. J Clin Psychiatry 2004;65:1679–1687. CrossRefGoogle ScholarPubMed
12 Bowden, CL, Calabrese, JR, Ketter, TA, Sachs, GS, White, RL, Thompson, TR. Impact of lamotrigine and lithium on weight in obese and nonobese patients with bipolar I disorder. Am J Psychiatry 2006;163:1199–1201. CrossRefGoogle ScholarPubMed
13 Vestergaard, P, Poulstrup, I, Schou, M. Prospective studies on a lithium cohort. 3. Tremor, weight gain, diarrhea, psychological complaints. Acta Psychiatr Scand 1988;78:434–441. CrossRefGoogle ScholarPubMed
14 Lipkovich, I, Citrome, L, Perlis, R et al. Early predictors of substantial weight gain in bipolar patients treated with olanzapine. J Clin Psychopharmacol 2006;26:316–320. CrossRefGoogle ScholarPubMed
15 Correll, CU, Frederickson, AM, Kane, JM, Manu, P. Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics. Bipolar Disord 2008;10: 788–797. CrossRefGoogle ScholarPubMed
16 Williams, LJ, Pasco, JA, Henry, MJ et al. Lifetime psychiatric disorders and body composition: a population-based study. J Affect Disord 2009;118:173–179. CrossRefGoogle ScholarPubMed
17 Pasco, JA, Henry, MJ, Kotowicz, MA et al. Serum leptin levels are associated with bone mass in nonobese women. J Clin Endocrinol Metab 2001;86:1884–1887. Google ScholarPubMed
18 World Health Organisation. Obesity: preventing and managing the global epidemic. World Health Organisation Technical Report Series 1995: 894. Google Scholar
19 World Health Organisation. Obesity – preventing and managing the global epidemic: report of a WHO consultation on obesity. Geneva: World Health Organisation, 1998.Google Scholar
20 Pasco, JA, Kotowicz, MA, Henry, MJ, Nicholson, GC. Impact of changing the criteria for diagnosing diabetes in Australia. Med J Aust 2002;176:353–354. CrossRefGoogle ScholarPubMed
21 Susce, MT, Villanueva, N, Diaz, FJ, de Leon, J. Obesity and associated complications in patients with severe mental illnesses: a cross-sectional survey. J Clin Psychiatry 2005;66:167–173. CrossRefGoogle ScholarPubMed
22 Elmslie, JL, Porter, RJ, Joyce, PR, Hunt, PJ, Shand, BI, Scott, RS. Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls. Aust NZ J Psychiatry 2009;43:53–60. CrossRefGoogle ScholarPubMed
23 Fleet-Michaliszyn, SB, Soreca, I, Otto, AD et al. A prospective observational study of obesity, body composition, and insulin resistance in 18 women with bipolar disorder and 17 matched control subjects. J Clin Psychiatry 2008;69:1892–1900. CrossRefGoogle ScholarPubMed
24 Wildes, JE, Marcus, MD, Fagiolini, A. Obesity in patients with bipolar disorder: a biopsychosocial-behavioral model. J Clin Psychiatry 2006;67:904–915. CrossRefGoogle ScholarPubMed
25 Belmaker, RH, Agam, G. Major depressive disorder. N Engl J Med 2008;358:55–68. CrossRefGoogle ScholarPubMed
26 Wang, GJ, Volkow, ND, Logan, J et al. Brain dopamine and obesity. Lancet 2001;357:354–357. CrossRefGoogle ScholarPubMed
27 Thakore, JH, Richards, PJ, Reznek, RH, Martin, A, Dinan, TG. Increased intra-abdominal fat deposition in patients with major depressive illness as measured by computed tomography. Biol Psychiatry 1997;41:1140–1142. CrossRefGoogle ScholarPubMed
28 Bjorntorp, P, Rosmond, R. Obesity and cortisol. Nutrition 2000;16:924–936. CrossRefGoogle ScholarPubMed
29 Weber-Hamann, B, Hentschel, F, Kniest, A et al. Hypercortisolemic depression is associated with increased intra-abdominal fat. Psychosom Med 2002;64:274–277. CrossRefGoogle ScholarPubMed
30 McIntyre, RS, Mancini, DA, Basile, VS, Srinivasan, J, Kennedy, SH. Antipsychotic-induced weight gain: bipolar disorder and leptin. J Clin Psychopharmacol 2003;23: 323–327. CrossRefGoogle ScholarPubMed
31 Brietzke, E, Stertz, L, Fernandes, BS et al. Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord 2009;116:214–217. CrossRefGoogle ScholarPubMed
32 Soreca, I, Fagiolini, A, Frank, E, Goodpaster, BH, Kupfer, DJ. Chronotype and body composition in bipolar disorder. Chronobiol Int 2009;26:780–788. CrossRefGoogle ScholarPubMed
33 Masand, PS, Fazal, FS, Patkar, AA. Safety considerations in pharmacotherapy of bipolar disorder. CNS Spectr 2004;9:16–26. CrossRefGoogle ScholarPubMed
34 Bond, DJ, Kauer-Sant'Anna, M, Lam, RW, Yatham, LN. Weight gain, obesity, and metabolic indices following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM). J Affect Disord 2010;124:108–117. CrossRefGoogle ScholarPubMed
35 Henry, MJ, Pasco, JA, Nicholson, GC, Seeman, E, Kotowicz, MA. Prevalence of osteoporosis in Australian women: Geelong Osteoporosis Study. J Clin Densitom 2000;3:261–268. CrossRefGoogle ScholarPubMed